Webinars on demand

Join Illumina for an educational webinar on the new EU IVD Regulation.

Register for this webinar to understand Why spatial relationships are important in tumour biology.

Pathology testing is helping to bring more clarity about disease and treatments to patients across the world. The insights that new techniques bring in this field are time sensitive, yet, these complex workflows often rely heavily on lab staff, repetitive manual steps, and have issues scaling.

Register for this webinar and hear Craig Johnson of Automata discuss how insights from new pathology testing techniques are helping the field to bring more clarity about disease and treatments to patients across the world.

In this webinar, Dr. Amelie Bonafond will present the current sequencing (via whole-exome sequencing) of all the patients with common T2D visiting the department of Diabetology of Liège Hospital (n > 4000 participants).

Inhibitors of the programmed cell death-1 (PD-1/PD-L1) signaling axis are approved to treat non-small cell lung cancer (NSCLC) patients. However, most NSCLC patients do not respond to PD-(L)1 blockade as single agents, and intratumoral immune infiltrates involved in the response to these therapies remain poorly characterized.

Genomic profiling in precision oncology is transforming cancer care for your patients.

Patients diagnosed with CML 20 years ago could live for around five years.

Leaders of the digital pathology associations in Europe (ESDIP), United States (DPA) and Japan (JDPA) have joined forces to accelerate the adoption of digital pathology.

ChipCytometry™ is a novel precise spatial multiplexing imaging platform that combines iterative immuno-fluorescent staining with high-dynamic range imaging to facilitate quantitative phenotyping with single-cell resolution.

The spread of breast cancer to lymph nodes is a crucial factor in determining patient outcome and treatment.

In this webinar, Dr. Jonathan Nowak and Grady Carlson discuss the application of digital pathology and multiplex imaging to study gastrointestinal cancers with a focus on profiling all cell types in the tumor microenvironment.